INTAS DRHP PDF

Read more about Intas Pharma files draft prospectus for IPO on Business Standard. Drug maker Intas Pharmaceuticals today said it has filed. Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public. Intas Pharma DRHP News: Latest and Breaking News on Intas Pharma DRHP. Explore Intas Pharma DRHP profile at Times of India for photos, videos and latest .

Author: Faelrajas Mazulrajas
Country: Estonia
Language: English (Spanish)
Genre: Literature
Published (Last): 11 December 2005
Pages: 487
PDF File Size: 6.78 Mb
ePub File Size: 11.11 Mb
ISBN: 169-4-20484-962-3
Downloads: 82763
Price: Free* [*Free Regsitration Required]
Uploader: Nilar

It has also extended rrhp presence into other therapy areas such as gynecology, infertility, arthritis and the respiratory. Medical Council of India MCI will investigate a complaint against 11 doctors from Madhya Pradesh who are charged with accepting foreign jaunts sponsored by pharmaceutical company.

Intas Pharma DRHP: Latest News, Videos and Photos of Intas Pharma DRHP | Times of India

The promoters of the company are Mr. Enquiry Thanks for contacting us! It is currently ranked as the 12th largest pharmaceutical company in the country with a 2.

We will get in touch with you shortly. Visit Our Digital Magazine: MCI to probe foreign jaunts by MP doctors. Sources said the group has started a process to sell drug discovery services company Advinus Therapeutics, drawing interest from private equity funds Kedaara Capital and True North as well as from strategic players, GVK Biosciences and Lambda, a unit of Intas Pharma. At present, domestic companies are marketing their products only in emerging markets, but the largest and most lucrative market for all pharmaceuticals — the US — is the next stop.

  BISS ZUM MORGENGRAUEN ONLINE LESEN PDF

Rahul Gandhi listed as ‘non-Hindu’. Drugs sold sans regulator’s nod, safety studies. Intas Pharma eyes hospitals in Europe, US.

The IPO will be made through a public issue of equity shares of face value of Rs. Monday, 31 December ChrysCap backs Curatio in latest pharma bet. Intas Pharma merges group companies, subsidiaries.

Intas Pharmaceuticals files DRHP for IPO

The Ahmedabad-based company is considering licensing agreements with hospital-based businesses in these markets. All rights reserved Disclaimer.

Intas Pharma is a vertically integrated Indian pharmaceutical company with global operations, engaged in the development, manufacture and marketing of pharmaceutical formulation. Intas Pharma buys Spanish company’s hospital business. Sun Pharma in early talks to buy Intas Pharma.

The company is present in various major therapy areas such as those relating to neurology, psychiatry, cardiology, pain management, gastroenterology, diabetology, nephrology, urology, anti-infective therapy, dermatology, gynecology, respiratory system, oncology, intqs care and ophthalmology with a strong focus on chronic xrhp areas relating to neurology, psychiatry, cardiology and diabetology.

Subscribe to BioSpectrum India. Intas Pharma launches first etanercept biosimilar. Mon, Dec 31, Updated Please note that comments are moderated and are generally published if they are on-topic and not abusive.

Please fill the all fields. In what could further strengthen its business in European and non-European countries, Ahmedabad based Intas Pharmaceuticals Ltd has intaa hospital business of Combino Pharm in Spain and Portugal for an undisclosed sum.

  BELBIN TEAM ROLES INVENTORY PDF

Web Interface Conceived and Powered By: Please click here to Sign-in or Sign-up. Its crhp are marketed in over 60 countries, either directly, through its subsidiaries or indirectly, through supply, distribution and other arrangements with various leading global pharmaceutical companies.

From around the Web. Intas Pharma files for an IPO.

Intas Pharmaceuticals files DRHP for IPO –

Nimish Hasmukhbhai Chudgar, Dr. Intas to buy Teva’s UK, Ireland assets for mn pounds. New Delhi, May 26 RPG Life Sciences has sold its Gujarat-based biotechnology unit to Intas Pharmaceuticals for Rs 25 crore to focus on core areas of business and improve long-term competitiveness in a rapidly changing market. Desi pharma companies top in biosimilars globally. Chandra kicks off divestment plan. Hyderabad-based pharma giant Aurobindo snaps up Portuguese co for Rs crore.

Binish Hasmukh Chudgar, Mr. Email Enter a valid email address. According to sources, the company has begun the groundwork for the IPO and approached merchant bankers a couple of months ago. Drug-maker Intas Pharmaceuticals has merged all its group companies and subsidiaries over concerns about low profits.